NC
Neil Cashman bought $39K of PMN stock
Neil Cashman, Chief Scientific Officer of ProMIS Neurosciences Inc. (PMN), bought 10,000 shares of PMN stock worth $39K, per an SEC Form 4 filed Nov 3, 2026.
It was an open-market purchase.
The trade happened on Nov 2, 2026, 1 day before it was made public.
PMN has moved +38.7% since the trade date, from $3.00 to $4.16 (Nov 6, 2026 close).
- Traded
- Nov 2, 2026
- Disclosed
- Nov 3, 2026
- Filing delay
- 1 day
- Price since
- +38.7%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4